Org 5594010505Economic activity was not specified by tax authority · NACE 0000Est. 20220 employees
Revenue 2025
SEK 0
EBITDA margin
—
-52% vs 2024
Equity ratio
100.0%
Financial strength
Net profit 2025
SEK -2K
-52% vs 2024
EBITDA — year on yearSEK millionsKey figuresAnnual report 2025
Revenue
SEK 0
—
EBITDA
SEK -2K
-52%
Net profit
SEK -2K
-52%
Total assets
SEK 20K
-9%
Equity
SEK 20K
-9%
Employees
0
—
Company information
Legal name
Druggable Pharma International AB
Org number
5594010505
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
13 oktober 2022
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas i förening av ledamoten suppleanten
Company purpose
Aktiebolaget ska bedriva konsultverksamhet inom medicin samt forskning och utveckling av läkemedel, särskilt inom områdena cancer och infektioner, ävensom idka därmed förenlig verksamhet.
Contact
Address
Email
catharina.svanborg@hamletpharma.co
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.